Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Epstein-Barr Virus Infections × Valacyclovir × Clear all

Phase

Phase NA 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Epstein-Barr Virus Infections 1 Cytomegalovirus Infections 1

Interventions

Blood Specimen Collection 2 Valganciclovir 1 Valacyclovir 1 Radiotherapy, Intensity-Modulated 1 Phantoms, Imaging 1 Magnetic Resonance Spectroscopy 1 Biopsy 1 Acyclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07294547 2025-12-19

Is Valacyclovir Non-inferior to Valganciclovir as CMV and EBV Prophylaxis in Kidney Transplant Recipients? A Single-Center Prospective Randomized Pilot Study

National Taiwan University Hospital

Phase NA Recruiting

Cytomegalovirus Infections, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡